Abstract
Background
Treatment of patients with a significant percentage of total body surface area of deep burns requires intensive care, including conservative therapy and debridement and split-thickness skin grafting surgery. Skin graft failure (SGF) is an absolute indication for regrafting and thus, it increases the number of reconstructive surgeries, prolongs the duration of hospital stay, and increases the risk of hospital-acquired infections. This study aims to identify factors associated with SGF, which can help quantify the risk of skin graft failure and eventually modify the disease course by pharmacological interventions.
Methods
A retrospective single centric longitudinal observational study of a cohort of adult burn patients admitted immediately after the injury to the Burn Intensive Care Unit was performed.
Results
Sixty-nine burn patients were included. Thirty-three patients (47.8%) underwent at least one regrafting due to skin graft failure. In simple regression analyses, we identified several baseline factors associated with skin graft failure. In multiple regression analyses, after controlling for confounding of percentage of total body surface area of deep burns, white blood cell count remained associated with skin graft failure.
Conclusions
Patients with higher baseline white blood cell count have higher risk of skin graft failure compared to those with the same percentage of total body surface area of deep burns but lower baseline white blood cell count.
Level of evidence: Level V, risk/prognostic
Similar content being viewed by others
Data Availability
The dataset used for the purpose of this study will be made available by the corresponding author upon request.
References
European Burns Association (2017) European Practice Guidelines for Burn Care. In Internet: https://www.euroburn.org/wp-content/uploads/EBA-Guidelines-Version-4-2017.pdf
Jeschke MG et al (2020) Burn injury. Nat Rev Dis Primers 6(1):11
Smolle C et al (2017) Recent trends in burn epidemiology worldwide: a systematic review. Burns 43(2):249–257
Ahuja RB (2016) ISBI practice guidelines for burn care: editorial. Burns 42(5):951–952
Isitt CE et al (2016) An analysis of surgical and anaesthetic factors affecting skin graft viability in patients admitted to a Burns Intensive Care Unit. Scars Burn Heal 2:2059513116642089
Blume PA, Key JJ (2012) Skin grafts. Low extremity soft tissue & cutaneous plastic surgery. Edinburgh: Elsevier. 1:207
Erik von Elm M, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JPJAIM (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. 147:573e577
Pham TN et al (2008) American Burn Association practice guidelines burn shock resuscitation. J Burn Care Res 29(1):257–266
Hatef DA, Hollier LH Jr (2009) Pathophysiologic response to severe burn injury. J Craniofac Surg 20(4):1300–1301
Mulder PP et al (2021) Persistent systemic inflammation in patients with severe burn injury is accompanied by influx of immature neutrophils and shifts in T cell subsets and cytokine profiles. Front Immunol 11:3642
Jeschke MG et al (2007) Burn size determines the inflammatory and hypermetabolic response. Crit Care 11(4):R90
Balk RAJV (2014) Systemic inflammatory response syndrome (SIRS) where did it come from and is it still relevant today? Virulence 5(1):20–26
Hirche C, Citterio A, Hoeksema H, Koller J, Lehner M, Martinez JR, Monstrey S, Murray A, Plock JA, Sander F, Schulz A (2017) Eschar removal by bromelain based enzymatic debridement (Nexobrid®) in burns: An European consensus. Burns 43(8):1640–53
Hirche C, Almeland SK, Dheansa B, Fuchs P, Governa M, Hoeksema H, Korzeniowski T, Lumenta DB, Marinescu S, Martinez-Mendez JR, Plock JA (2020) Eschar removal by bromelain based enzymatic debridement (Nexobrid®) in burns: European consensus guidelines update. Burns 46(4):782–96
Varkey M et al (2019) Skin bioprinting: the future of burn wound reconstruction? Burns Trauma 7:4
Larson KW, Austin CL, Thompson SJ (2020) Treatment of a full-thickness burn injury with NovoSorb biodegradable temporizing matrix and RECELL autologous skin cell suspension: a case series. J Burn Care Res 41(1):215–219
Funding
This research did not receive specific funding but was performed as part of the employment of the authors at Pavol Jozef Safarik University, Hospital Agel Kosice-Saca, and L. Pasteur University Hospital.
Author information
Authors and Affiliations
Contributions
Michala Gayova: concept and design, data collection, drafting the article; Jan Babik: concept, design, critical review of the manuscript and approval of its final version; Peter Lengyel: critical review of the manuscript and approval of its final version; Jana Katuchova: critical review of the manuscript and approval of its final version; Jakub Gazda: concept, design, statistical analysis, critical review of the manuscript and approval of its final version. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval
The study protocol is in accordance with the 1964 Declaration of Helsinki and its later amendments and with good clinical practice principles. The study protocol was approved by the Ethical Committee of Hospital Agel Kosice-Saca, a.s. on February 2, 2022.
Patient consent
Ndue to the retrospective nature of data collection and the complete anonymity of the records, the committee waived the need for specific patients’ informed consent.
Conflict of interests
Michala Gayova, Jan Babik, Peter Lengyel, Jana Katuchova, and Jakub Gazda declare no conflict of interest.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gayova, M., Babik, J., Lengyel, P. et al. Baseline factors associated with split-thickness skin graft failure in burn patients: a retrospective observational analysis of a cohort of 69 burn patients. Eur J Plast Surg 46, 619–624 (2023). https://doi.org/10.1007/s00238-023-02049-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00238-023-02049-1